Siegfried opens new global R&D Center for Drug Substances in Evionnaz
New facility to drive development excellence and further growth
Together with the R&D Center in Zofingen, it will offer chemical process R&D and analytical development services for Siegfried’s global Drug Substances network. With workspaces for over 100 highly skilled specialists and 40 new jobs created, the R&D Center strengthens Siegfried’s development excellence in phase II and III supporting the company’s EVOLVE+ strategy.
Marcel Imwinkelried, CEO of Siegfried: “The new R&D Center in Evionnaz significantly enhances our Drug Substances network and demonstrates our unwavering commitment to providing cutting-edge research and development capabilities for our customers. It will be a key element in driving development excellence as part of our EVOLVE+ strategy and represents another pivotal step in strengthening our position among the top providers in the CDMO sector.”
Most read news
Other news from the department research and development
These products might interest you
Pharmaceutical Substances by Thieme Verlag
Look up Industrial Syntheses of 2,600 APIs
Your tool for Syntheses, Patents and Applications – Pharmaceutical Substances
KNAUER IJM NanoScaler by KNAUER
Efficient formulation of lipid nanoparticles for RNA-based therapies
Optimise drug encapsulation from 1 ml to hundreds of millilitres with minimal drug input
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.